Fieldpoint Private Securities’s AstraZeneca AZN Stock Holding History

Fieldpoint Private Securities’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$222K	Buy	1,679 +807	+93%	+$106K	0.06%	242
2022 Q1	$116K	Buy	872 +52	+6%	+$6.24K	0.02%	404
2021 Q4	$96K	Buy	820 +107	+15%	+$12.6K	0.02%	451
2021 Q3	$86K	Buy	713 +129	+22%	+$15K	0.02%	442
2021 Q2	$66K	Buy	584 +56	+11%	+$6.14K	0.01%	513
2021 Q1	$52K	Sell	528 -32	-6%	-$3.22K	0.01%	554
2020 Q4	$56K	Buy	+560	New	+$59.3K	0.01%	463
2017 Q4	–	Sell	-1,322	Closed	-$90K	–	403
2017 Q3	$90K	Buy	1,322 +517	+64%	+$32.7K	0.04%	294
2017 Q2	$55K	Hold	805	–	–	0.04%	107
2017 Q1	$50K	Buy	+805	New	+$46.9K	0.04%	195

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fieldpoint Private Securities's AZN Position: Q2 2022 in Review

Fieldpoint Private Securities increased its AstraZeneca (AZN) stake by 93% in Q2 2022, buying an estimated $106K and bringing the position to 1,679 shares worth $222K. The position accounts for 0.06% of the portfolio, ranked #242.

Fieldpoint Private Securities first reported a position in AZN in Q1 2017 and has held it in 10 quarters since. 1,016 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

Fieldpoint Private Securities held 1,679 shares of AstraZeneca worth $222K as of Q2 2022.
Fieldpoint Private Securities bought 807 AstraZeneca shares in Q2 2022, an estimated $106K.
AstraZeneca made up 0.06% of Fieldpoint Private Securities's portfolio in Q2 2022, its #242 holding.
Fieldpoint Private Securities first reported a position in AstraZeneca in Q1 2017 and has held it in 10 quarters since.
1,016 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.